Determination of the antimicrobial activity of a gel composition based on a flavonoid complex and benzidamine hydrochloride intended for the treatment of periodontal diseases in orthodontic patients
DOI:
https://doi.org/10.11603/2311-9624.2023.2-3.14004Keywords:
periodontal dressing, gel composition, antimicrobial properties, flavonoids, benzidamine hydrochloride, orthodontic patients, periodontal microfloraAbstract
Summary. It is important to solve the problem of complex treatment and prevention of periodontal diseases in orthodontic patients by developing new drugs that have antimicrobial, anti-inflammatory, antioxidant effects and are included in effective treatment regimens. Orthodontic treatment with fixed orthodontic appliances contributes to a significant decrease in the level of individual oral hygiene against the background of oxidative stress. Therefore, the aggressiveness of periodontal pathogenic microflora increases, which contributes to the deepening of the inflammatory process in the tissues of the periodontal complex.
The aim of the study – to determine the antimicrobial activity of the developed periodontal gel composition based on flavonoid complex and benzidamine hydrochloride against microorganisms isolated from periodontal pockets of orthodontic patients with dystrophic-inflammatory diseases of periodontal tissues.
Materials and Methods. The efficacy of antimicrobial preservatives of the patented gel composition “Benzidaflaziverdine” (GCB) and the comparison drug “Cholisal” was evaluated according to the recommendations given in the State Pharmacopoeia of Ukraine (SPU). GCB samples were inoculated with suspensions of daily cultures of reference strains of S. aureus, P. aeruginosa, C. albicans and Aspergillus so that the final concentration of colony forming units (CFU) was 105-106 per ml. Isolates obtained from the oral cavity and periodontal pockets of orthodontic patients (S. aureus, S. pyogenes, S. mutans, E. faecalis, Rothia sp, bacteria of the Actinomycetaceae family, P. aeruginosa, C. albicans) were also used. Samples were taken after 2, 7, 14 and 28 days and the concentration of CFU of microorganisms was determined. Two methods were used to determine the antimicrobial activity: the standard “well” method regulated by the SPU, as well as a modification of the suspension method for determining the specific activity of disinfectants and other antimicrobial substances and compounds. To assess the reduction in the concentration of microorganisms, the decimal logarithm of the reduction in CFU in the samples (Log10 rate of reduction) was calculated.
Results and Discussion. The results of using a modification of the suspension method, the peculiarity of which was to dilute equal proportions of GCB with a bacterial suspension, showed a well-pronounced antibacterial activity of GCB. At the same time, the activity of GCB against methicillin-resistant S. aureus isolate did not differ from that against sensitive isolates. The activity of GCB can be characterized as species-specific; the effect on individual isolates of the same species differed slightly. GCB activity was high against streptococci, Rothia sp. and pseudomonas (P. aeruginosa). For S. aureus, S. pyogenes and C. albicans, the dynamics of the decrease in CFU during exposure to GCB for 40 minutes was determined. It was found that the maximum Lоg10 rate of reduction of CFU of staphylococcus aureus and pyogenic streptococcus occurred in the first 10-15 minutes of incubation. Thus, analyzing the results obtained, we found no statistically significant differences between the absolute values of Lоg10 CFU reduction for GCB and the comparison drug “Cholisal”.
Conclusions. The developed GCB in terms of its antimicrobial properties fully meets the requirements of the SPU in terms of the indicator “antimicrobial activity of preservatives”. The probable synergism of a low dose of nipagine introduced into the composition and the antimicrobial properties of benzidamine hydrochloride, which is in optimal ratio with Proteflazid® (flavonoid complex), provided high antimicrobial properties of the developed drug, which can be recommended as a periodontal dressing for the treatment of periodontal tissue diseases in orthodontic patients in preparation for the active period of orthodontic treatment, and in cases of stopped remission at different periods of bracket systems use.
References
Caton, J.G., Armitage, G., Berglundh, T., Chapple, I.L.C., Jepsen, S., Kornman, K.S., Mealey, B.L., Papapanou, P.N., Sanz, M., & Tonetti M.S. (2018). A new classification scheme for periodontal and peri-implant diseases and conditions – Introduction and key changes from the 1999 classification. J. Clin. Periodontology, 45(20), S1-S8. DOI: 10.1111/jcpe.12935. PMID: 29926489. DOI: https://doi.org/10.1111/jcpe.12935
Kovach, I.V., Alieksieienko, N.V., & Zelinskyi, A.L. (2019). Osnovni faktory ryzyku vynyknennia zapalnykh zakhvoriuvan parodontu u osib molodoho viku [The main risk factors for the occurrence of inflammatory periodontal diseases in young people]. Visnyk Stomatolohii. – Bulletin of Dentistry, 32(2), 66-71.
DOI: 10.35220/2078-8916-2019-32-2-65-68 [in Ukrainian]. DOI: https://doi.org/10.35220/2078-8916-2019-32-2-65-68
Veynachter, T., Orti, V., Moulis, E., Rousseau, H., Thilly, N., Anagnostou, F., Jeanne, S., & Bisson, C. (2020). Prevalence and Associated Factors of Self-Reported Gingival Bleeding: A Multicenter Study in France. Int. J. Environ. Res. Public Health, 17(22), 8563. DOI: 10.3390/ijerph17228563. PMID: 33218143; PMCID: PMC7698919. DOI: https://doi.org/10.3390/ijerph17228563
Tankova, H., Mitova, N., Rashkova, M., & Popova, H. (2021). Risk factors and gingival inflammation in children aged 10 to 14 years – an epidemiological study. J. of IMAB, 27(4), 4092-4097. DOI: 10.5272/jimab.2021274.4092. DOI: https://doi.org/10.5272/jimab.2021274.4092
De David, S.C., Mário, T.G., De Freitas, G.C., Kantor-ski, K.Z., Wikesjö, U.M.E., & Moreira, C.H.C. Correlation between plaque control and gingival health using short and extended oral hygiene intervals. Clin. Oral. Investig., 22(7), 2593-2597. DOI: 10.1007/s00784-018-2358-5. DOI: https://doi.org/10.1007/s00784-018-2358-5
Epub 2018 Feb 15. PMID: 29450737.
Borysenko, A.V., Batih, I.V., Kuzniak, N.B., & Batih, V.M. (2022). Vplyv ortodontychnoho likuvannia na parodont (ohliad literatury) [The impact of orthodontic treatment on the periodontium (literature review)]. Suchasna Stomatolohiia – Modern Dentistry, 1-2, 68-75. DOI: 10.33295/1992-576X-2022-1-2-68 [in Ukrainian]. DOI: https://doi.org/10.33295/1992-576X-2022-1-2-68
Hodovanyi, O. Martovlos, A., & Hodovana, O. (2019). Zakhvoriuvannia parodontu ta anomalii i deformatsii zuboshchelepnoi systemy u khvorykh riznoho viku (stan problemy ta shliakhy yii vyrishennia) [Periodontal disease and anomalies and deformations of the maxillofacial system in patients of various ages (state of the problem and ways to solve it]. Pratsi Naukovoho tovarystva imeni Shevchenka. Medychni nauky – Proceedings of the Shevchenko Scientific Society. Medical sciences, 55(1), 10-30. DOI: 10.25040/ntsh2019.01.02 [in Ukrainian]. DOI: https://doi.org/10.25040/ntsh2019.01.02
Alsulaimani, L., Alqarni, H., Akel, M., & Khalifa, F. (2023). The Orthodontics-Periodontics Challenges in Integrated Treatment: A Comprehensive Review. Cureus, 15(5) DOI: 10.7759/cureus.38994. PMID: 37323308. DOI: https://doi.org/10.7759/cureus.38994
PMCID: PMC10262598.
Fastovets, O.O., & Samoilenko, V.A. (2016). Donozolohichna diahnostyka parodontolohichnykh uskladnen u ortodontychnykh khvorykh pry zastosuvanni neznimnoi aparatury [Pre-hospital diagnosis of periodontal complications in orthodontic patients with the use of fixed appliances]. Visnyk stomatolohii – Bulletin of Dentistry, 2, 56-60 [in Ukrainian].
Newton, J.T., & Asimakopoulou, K. (2015). Managing oral hygiene as a risk factor for periodontal disease: A systematic review of psychological approaches to behaviour change for improved plaque control in periodontal management. Journal of Clinical Periodontology, 42 (S16), S36-S46. DOI: 10.1111/jcpe.12356. DOI: https://doi.org/10.1111/jcpe.12356
Papageorgiou, S.N., Xavier, G.M., Cobourne, M.T., & Eliades, T. (2018). Effect of orthodontic treatment on the subgingival microbiota: A systematic review and meta-analysis. Orthod. Craniofac. Res., 21(4), 175-185.
DOI: 10.1111/ocr.12237. DOI: https://doi.org/10.1111/ocr.12237
Menéndez López-Mateos, C., Menéndez López-Mateos, M.L., Aguilar-Salvatierra, A., Gómez-Moreno, G., Carreño, J. C., Khaldy, H., & Menéndez-Núñez, M. (2022). Salivary Markers of Oxidative Stress in Patients Undergoing Orthodontic Treatment with Clear Aligners versus Self-Ligating Brackets: A Non-Randomized Clinical Trial. J. Clin. Med., 11(12), 3531. DOI: 10.3390/jcm11123531. PMID: 35743601. PMCID: PMC9225360. DOI: https://doi.org/10.3390/jcm11123531
Marincak Vrankova, Z., Rousi, M., Cvanova, M., Gachova, D., Ruzicka, F., Hola, V., J. Lochman, J., Izakovicova Holla, L., Brysova A., & Borilova Linhartova, P. (2022). Effect of fixed orthodontic appliances on gingival status and oral microbiota: a pilot study. BMC Oral. Health, 22(455). DOI: 10.1186/s12903-022-02511-9. DOI: https://doi.org/10.1186/s12903-022-02511-9
Kovach, I.V., & Lavreniuk, Ya.V. (2016). Stan mikrobiotsenozu porozhnyny rota u ditei z neznimnoiu ortodontychnoiu tekhnikoiu [The state of microbiocenosis of the oral cavity in children with fixed orthodontic appliances]. Innovatsii v Stomatolohii – Innovations in Dentistry, 1, 15-19 [in Ukrainian].
Melnyk, V.S., Horzov, L.F., & Izai, M.E. (2019). Zminy oralnoho mikrobiomu ditei pry likuvanni neznimnoiu ortodontychnoiu aparaturoiu [Changes in the oral microbiome of children during treatment with fixed orthodontic equipment]. Visnyk problem biolohii i medytsyny – Bulletin of problems in biology and medicine, 1(1), 343-347. DOI: 10.29254/2077-4214-2019-1-1-148-343-347 [in Ukrainian]. DOI: https://doi.org/10.29254/2077-4214-2019-1-1-148-343-347
Petrushanko, T.O., Popovych, I.Iu., & Moshel, T.M. (2020). Otsinka dii khvorobotvornykh faktoriv u patsiientiv iz heneralizovanym parodontytom [Evaluation of the effect of pathogenic factors in patients with generalized periodontitis]. Klinichna stomatolohiia – Clinical Dentistry, 2, 24-32.
DOI: 10.11603/2311-9624.2020.2.11398 [in Ukrainian]. DOI: https://doi.org/10.11603/2311-9624.2020.2.11398
Guo, R., Lin, Y., Yunfei Zheng, Y., & Li, W. (2017). The microbial changes in subgingival plaques of orthodontic patients: a systematic review and meta-analysis of clinical trials. BMC Oral Health, 2, 17(1), 90.
DOI: 10.1186/s12903-017-0378-1. DOI: https://doi.org/10.1186/s12903-017-0378-1
Hodovanyi, O.V., Hodovana, O.I., Shandra, M.S., Kliuchivska, O.Yu., & Stoika, R.S. (2022). Zasib u formi helevoi kompozytsii «Benzydaflaziverdyn» z prolonhovanoiu diieiu dlia likuvannia zakhvoriuvan tkanyn parodonta (Patent Ukrainy na vynakhid № 125272) [Remedy in the form of a gel composition “Benzidaflaziverdine” with a prolonged action for the treatment of periodontal tissue diseases (Ukrainian Patent for the Invention No. 125272)]. MPK, A61K 9/00, № a 2020 08196 [in Ukrainian].
Pavliuk, B.V., Lukashiv, O.Ya., Pokryshko, O.V., Chubka, M.B., & Hroshovyi, T.A. (2019). Doslidzhennia antymikrobnoi aktyvnosti konservantiv z metoiu rozrobky skladu kombinovanoho heliu dlia mistsevoho likuvannia opikiv [Study of the antimicrobial activity of preservatives using the means of developing the composition of a combined gel for the local treatment of burns]. Farmatsevtychnyi Chasopys – Pharmaceutical Journal, 3, 35-42 [in Ukrainian]. DOI: https://doi.org/10.11603/2312-0967.2019.3.10409
Okukawa, M., Yoshizaki, Y., Tanaka, M., Yano, S., & Nonomura, Y. (2021). Antibacterial Activity of the Mixed Systems Containing 1,2-Dodecanediol against Staphylococcus aureus and Staphylococcus epidermidis. J. Oleo. Sci., 70(6), 787-797. DOI: 10.5650/jos.ess20362. Epub 2021 May 7. PMID: 33967172. DOI: https://doi.org/10.5650/jos.ess20362
(2016). Derzhavna Farmakopeia Ukrainy: v 3 t. Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv» [State Pharmacopoeia of Ukraine: in 3 volumes. State enterprise "Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicinal Products"]. Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv» [in Ukrainian].
Likarski zasoby. Nalezhna vyrobnycha praktyka: Nastanova ST-N MOZU 42-4.0:2016 [Medicines. Proper production practice: Guideline ST-N MOZU 42-4.0:2016] MOZ Ukrainy [in Ukrainian].
(2005). DSTU EN 1040:2004 Zasoby khimichni dezinfektsiini ta antyseptychni. Osnovna bakterytsydna aktyvnist. Chastyna 1. Metod vyprobovuvannia ta vymohy. Naukovo-vyrobnyche pidpryiemstvo TOV «Laboratoriia meddezkomp» [Chemical disinfectants and antiseptics. Main bactericidal activity. Part 1. Test method and requirements. Research and production enterprise “Meddezcomp Laboratory” LLC.]. Kyiv: Derzhspozhyvstandart Ukrainy [in Ukrainian].
(2005). DSTU EN 1275:2004 Zasoby khimichni dezinfektsiini ta antyseptychni. Osnovna funhitsydna aktyvnist. Metod vyprobovuvannia ta vymohy (stadiia 1) [Chemical disinfectants and antiseptics. Main fungicidal activity. Test method and requirements (stage 1)]. Naukovo-vyrobnyche pidpryiemstvo TOV «Laboratoriia meddezkomp». – Research and production enterprise “Meddezcomp Laboratory” LLC. K.: Derzhspozhyvstandart Ukrainy [in Ukrainian].
Ramanauskaite, E., & Machiulskiene, V. (2020). Antiseptics as adjuncts to scaling and root planing in the treatment of periodontitis: a systematic literature review. BMC Oral. Health, 20(1), 143.
DOI: 10.1186/s12903-020-01127-1. PMID: 32418540. PMCID: PMC7232842. DOI: https://doi.org/10.1186/s12903-020-01127-1
Hodovanyi, O.V., & Hodovana, O.I. (2019). Zastosuvannia preparativ «Tantum Verde®» u profilaktytsi ushkodzhen slyzovoi obolonky porozhnyny rota pry zastosuvanni neznimnoi ortodontychnoi tekhniky [The use of “Tantum Verde®” drugs in the prevention of damage to the mucous membrane of the oral cavity when using fixed orthodontic equipment]. Suchasna Stomatolohiia – Modern Dentistry, 3, 102-105. DOI: 10.33295/1992-576X-2019-3-102 [in Ukrainian].
Hodovanyi, O.V., & Hodovana, O.I. (2018). Osoblyvosti zastosuvannia rozchynu Tantum Verde® u pidhotovtsi parodontolohichnykh khvorykh do ortodontychnoho likuvannia [Peculiarities of the application of Tantum Verde® solution in the preparation of periodontal patients for orthodontic treatment]. Suchasna Stomatolohiia – Modern Dentistry, 5, 44-48 [in Ukrainian].
Marushko, Yu.V., & Asonov, A.O. (2018). Uzahalnennia danykh zastosuvannia benzydaminu hidrokhlorydu ta tsetylpirydyniiu khlorydu v klinichnii praktytsi [Generalization of data on the use of benzydamine hydrochloride and cetylpyridinium chloride in clinical practice]. Suchasna Pediatriia – Modern Pediatrics, 7 (95), 83-87 [in Ukrainian]. DOI: https://doi.org/10.15574/SP.2018.95.83
Klitynska, O.V. (2017). Tantum Verde® – preparat vyboru pry kompleksnii terapii stomatolohichnykh zakhvoriuvan [Tantum Verde® – the drug of choice in the complex therapy of dental diseases]. Suchasna stomatolohiia – Modern Dentistry, 1, 40-41 [in Ukrainian].
Matyash, V., Grynevych, O., & Broun, T. (2019). PROTEFLAZID®: clinical studies as evidence base of its antiviral activity. Polski Merkuriusz Lekarski, 46 (271), 30-31. PMID: 30810112.
Beketova, G., Kuznetsova, L., Grynevych, O., Broun, T., Momotiuk, L, Motuzka, O, & Yashchenko L. (2021). Analysis of the clinical trial results of the flavonoid effects on some cellular immunity indicators in children and adults. Polski Merkuriusz Lekarski, 49 (289), 44-53. PMID: 33713093.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 CLINICAL DENTISTRY
This work is licensed under a Creative Commons Attribution 4.0 International License.
